CEL-SCI Corp. (CVM)
5.26
+0.03
(+0.57%)
USD |
NYAM |
Dec 31, 16:00
5.27
+0.01
(+0.19%)
Pre-Market: 08:54
CEL-SCI Research and Development Expense (Annual): 15.89M for Sept. 30, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| AIM ImmunoTech, Inc. | 6.149M |
| IGC Pharma, Inc. | 3.655M |
| NovaBay Pharmaceuticals, Inc. | 0.042M |
| Protalix Biotherapeutics, Inc. | 12.97M |
| Palatin Technologies, Inc. | 14.90M |